PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19592641-8	2009	Blocking IL-4 signaling during the decay phase using the JAK inhibitor AG490 or the anti-IL-4R(alpha) Ab M1 abrogated the persistence of phosphorylated STAT6 observed in the V50-IL-4R(alpha)-expressing cells.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	71-76	interleukin 4	Homo sapiens	9-13	
22992805-8	2013	The IL-4-induced downregulation of melanogenesis was inhibited by treating NHMs with a JAK2 inhibitor AG490 or STAT6 siRNA.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	102-107	interleukin 4	Homo sapiens	4-8	
17264307-6	2007	We also demonstrated that IL-4 induced phosphorylation of Syk, p38, Erk-1/2, JNK, Jak-1, Jak-2, STAT6, and STAT1 and that treatment of cells with the inhibitors piceatannol, SB203580, PD98059, or AG490 reversed the ability of IL-4 to delay neutrophil apoptosis.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	196-201	interleukin 4	Homo sapiens	26-30	
16210363-9	2006	The actions of interferon-gamma and IL-4 are mediated through the Janus kinase 2/signal transducer and activator of transcription signaling pathway and could be abolished by treating with AG490, a specific inhibitor of Janus kinase 2.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	188-193	interleukin 4	Homo sapiens	36-40	
11709700-6	2001	We show that IL-4 or IL-13-induced IL-13Ralpha2 mRNA expression was inhibited by the ERK inhibitor U0126, the JAK inhibitor AG490 and, to a lesser extent, the p38 MAPK inhibitor SB203580.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	124-129	interleukin 4	Homo sapiens	13-17	
10845915-4	2000	AG-490 potently inhibited IL-4-mediated proliferation of both D10 and the IL-4-dependent cell line CT.4S.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	0-6	interleukin 4	Homo sapiens	26-30	
10845915-4	2000	AG-490 potently inhibited IL-4-mediated proliferation of both D10 and the IL-4-dependent cell line CT.4S.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	0-6	interleukin 4	Homo sapiens	74-78